Table 1.
Distribution of screening test results and disease status at enrolment.
| Screening results | Colposcopic-histologic diagnosis |
|||||
|---|---|---|---|---|---|---|
| Negative (%) | CIN1 (%) | CIN2 (%) | CIN3 (%) | Cancer (%) | Total (%) | |
| Cytology | ||||||
| NILM | 28,459 (97.3) | 490 (66.8) | 107 (73.3) | 230 (52.3) | 12 (40.0) | 29,298 (95.7) |
| ASC-US | 466 (1.6) | 79 (10.8) | 7 (4.8) | 37 (8.4) | 2 (6.7) | 591 (1.9) |
| LSIL | 237 (0.8) | 111 (15.1) | 20 (13.7) | 59 (13.4) | 3 (10.0) | 430 (1.4) |
| cHSIL+ | 95 (0.3) | 53 (7.2) | 12 (8.2) | 114 (25.9) | 13 (43.3) | 287 (0.9) |
| HPV testing | ||||||
| HPV- | 26,506 (90.6) | 90 (12.3) | 8 (5.5) | 9 (2.0) | 0 (0) | 26,613 (87.0) |
| HPV+ | 2751 (9.4) | 643 (87.7) | 138 (94.5) | 431 (98.0) | 30 (100) | 3993 (13.0) |
| Total | 29,257 (100) | 733 (100) | 146 (100) | 440 (100) | 30 (100) | 30,606 (100) |